RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$140.55
-2.96% today
Updated 2026-04-29
Market cap
$29.88B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$34 – $156
Volume
3.1M
Revolution Medicines Inc (RVMD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-25.15M | $1.21M | $-49.62M | $-100.06M | $-147.18M | $-224.40M | $-350.57M | $-557.44M | $-897.74M |
| Capital expenditures | $1.57M | $1.50M | $2.59M | $2.93M | $6.53M | $10.82M | $7.73M | $10.31M | $15.99M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $141000.00 | $855000.00 | $3.16M | $8.89M | $20.72M | $31.20M | $61.77M | $79.20M | $118.39M |
| Free cash flow | $-26.72M | $-286000.00 | $-52.20M | $-103.00M | $-153.71M | $-235.22M | $-358.30M | $-567.74M | $-913.73M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $88.48M | $4.88M | — | — | — | — |